Pharma & Competition Law - Latest Caselaw Update

Introduction

Competition law and enforcement is a perennial concern for clients in the pharma sector since this is a rapidly changing area due to increased enforcement and frequent appeals and litigation in pharma cases.

This webinar is suitable for anyone advising on competition law in the pharmaceutical sectors or who has clients in the life sciences or pharmaceutical industry and is advising on compliance issues, including competition law.

By viewing this webinar you will be up to date on the recent cases and judgments relevant to the pharma and biotech sectors in the EU and UK.

What You Will Learn

This webinar will cover the following:

• Overview of competition law enforcement in the pharmaceutical sector and features of the market that influence enforcement
• Practices that prevent market entry in the pharma sector - recent cases
  • Abusive rebates in the pharma sector, recent developments
  • Disparagement by dominant companies
  • Patent misuse and vexatious litigation
  • Pay-for-delay agreements
• Excessive pricing in pharma, EU and UK cases
• Cartels and bid-rigging and other restrictive agreements - cases in the pharma sector
• Mergers in the pharma & biotech sector
  • Theories of harm in pharma mergers and innovation and ‘killer acquisitions’
  • Referral mechanism from Member State competition authorities to the European Commission in relation to the pharmaceutical and biotech sectors